Abstract
Therapeutic engineering of glucagon-like peptide 1 (GLP-1) has enabled development of new medicines to treat type 2 diabetes. These injectable analogs......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
